Like your analysis, but It is quite controversy to exclude foreign gain/loss from NOPAT in some cases, especially with big difference floatation which in real cases actually help or pull down these companies. A part of revenue numbers come from selling prices (derives from forex currencies), not totally from volumes of sales.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Supreme Consolidated Resources Berhad, a distributor and warehouser of F&B products, aims to list on the ACE Market!
MQ Trader 558 views | 11 d ago
0:17
New IPO: O&G healthcare service provider, Metro Healthcare Berhad aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
stockmanmy
6,977 posts
Posted by stockmanmy > 2016-06-02 20:57 | Report Abuse
conclusion is obvious
Lihen has the highest turnover ratio. How fast assets are turnover. Faster the better.
Homeritz has the highest NOPAT margin suggesting pricing power.
For long term investors you want Lihen and Homeritz.